References
- Klastrup V, Hvass AM, Mackenhauer J, et al. Site of infection and mortality in patients with severe sepsis or septic shock. A cohort study of patients admitted to a Danish general intensive care unit. Infect Dis (Lond). 2016;48:726–731.
- Moreno RP, Menitz B, Adler L, et al. Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med. 2008;34:496–504.
- Rubulotta F, Marshall JC, Ramsay G, et al. Predisposition, insult/infection, response, and organ dysfunction: a new model for staging severe sepsis. Crit Care Med. 2009;37:1329–1335.
- Nelson GE, Pondo T, Toews K-A, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin Infect Dis. 2016;63:478–486.
- Muller MP, Low DE, Green KA, et al. Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada. Arch Intern Med. 2003;163:467–472.
- Tamayo E, Montes M, Vicente D, et al. Streptococcus pyogenes pneumonia in adults: clinical presentation and molecular characterization of isolates 2006-2015. PLoS One. 2016;11:e0152640.
- Carapetis JR, Jacoby P, Carville K, et al. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis off Publ Infect Dis Soc Am. 2014;59:358–365.
- Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis off Publ Infect Dis Soc Am. 2014;59:851–857.